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1043Dietary Sodium and HealthMore Than Just Blood PressureABSTRACTSodium is essential for cellular homeostasis and physiological function. Excess dietary sodium has been linked to ele-
vations in blood pressure (BP). Salt sensitivity of BP varies widely, but certain subgroups tend to be more salt sensitive.
The mechanisms underlying sodium-induced increases in BP are not completely understood but may involve alterations in
renal function, ﬂuid volume, ﬂuid-regulatory hormones, the vasculature, cardiac function, and the autonomic nervous
system. Recent pre-clinical and clinical data support that even in the absence of an increase in BP, excess dietary sodium
can adversely affect target organs, including the blood vessels, heart, kidneys, and brain. In this review, the investigators
review these issues and the epidemiological research relating dietary sodium to BP and cardiovascular health outcomes,
addressing recent controversies. They also provide information and strategies for reducing dietary sodium. (J Am Coll
Cardiol 2015;65:1042–50) © 2015 by the American College of Cardiology Foundation.S odium is essential for ﬂuid balance and cellularhomeostasis. Claude Bernard was the ﬁrst tohighlight the “milieu intérieur.” Walter Cannon
(1) more explicitly deﬁned homeostasis when he
referred to the “ﬂuid matrix” of the body and empha-
sized the role of sodium. In the past several decades,
there has been a tremendous amount of work
exploring dietary sodium and health. The amount of
sodium needed to maintain homeostasis in adults
is exceedingly low (<500 mg) compared with the
average intake of most Americans (>3,200 mg)
(2). We review the effects of dietary sodium on
blood pressure (BP) and outcomes, emphasizing that
excess sodium has direct adverse effects on
target organs, beyond the increased risk for hyperten-
sion (HTN). We also review strategies for reducing
sodium.
PATHOPHYSIOLOGY: SALT SENSITIVITY OF BP
BP responses to alterations in dietary sodium vary
widely, leading to the concept of salt-sensitive (SS)
BP (3,4). There are no standardized guidelines or
ﬁrm BP cutoffs for classifying patients as having SS
BP. If BP increases during a period of high dietary
sodium or declines during a period of low sodium, a
patient has SS BP. If there is no change in BP with
sodium restriction, a patient has salt-resistant (SR)
BP. Limited evidence supports the reproducibility
of these responses (5,6). Although individuals are
commonly dichotomized as SS or SR (3), BP responses
to sodium manipulation follow a Gaussian distribu-
tion (7,8). Table 1 lists groups that tend to be SR or
SS (4,9–14). Salt sensitivity in normotensive adults
predicts future HTN (14,15), and SS BP has beenassociated with increased mortality (16). Although
there is interest in studying the pathophysiology of
SS BP, there is less interest in its routine clinical
assessment (17).
PATHOPHYSIOLOGY: MECHANISMS OF
SODIUM-INDUCED INCREASES IN BP
The physiological mechanisms underlying SS BP are
not fully elucidated, but they involve alterations
in renal function, ﬂuid hormones, the vasculature,
the heart, and/or central sympathetic outﬂow (Central
Illustration). There are also genetic mechanisms
related to the SS phenotype (18–20).
Guyton’s studies demonstrated that sodium loading
caused extracellular volume expansion and volume-
loaded HTN in the context of induced renal dysfunc-
tion in dogs (21), consistent with clinical studies in
patients with chronic kidney disease (10). The deoxy-
corticosterone acetate–salt model of experimental
HTN in rats requires removal of 1 kidney, further sup-
porting the kidney’s role in expression of salt sensi-
tivity (22).
Impaired hormonal (renin-angiotensin-aldoste-
rone) responsiveness during a sodium manipulation
is linked to an SS BP response. Indeed, African Ameri-
cans have a blunted plasma renin response to sodium
manipulation (23). The molecular signaling pathways
involved in sodium-induced increases in BP are
not known but likely involve angiotensin II type 1
receptors (24), found in the renal and nonrenal
vasculature, and the central nervous system, which
are important for BP and/or ﬂuid regulation. Mice
lacking renal angiotensin II type 1 receptors become
SS (24).
CENTRAL ILLUSTRATION
High dietary sodium can potenti
total peripheral resistance. The c
TABLE 1 Salt Sensitivity in Various Groups*
Salt Resistant Salt Sensitive
Young Aged
Middle-aged Hypertensive
Normotensive African American
Caucasian Chronic kidney disease
History of pre-eclampsia
Low birth weight
*Data derived from Weinberger et al. (4), de Bier et al. (9), Koomans et al.
(10), Martillotti et al. (11), Weinberger (12,13), and Weinberger et al. (14)
ABBR EV I A T I ON S
AND ACRONYMS
AHA = American Heart
Association
BP = blood pressure
CV = cardiovascular
HTN = hypertension
LV = left ventricular
RCT = randomized
controlled clinical trial
SR = salt-resistant
SS = salt-sensitive
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ture has also been implicated in SS BP re-
sponses. Studies suggest that elevated dietary
sodium expands the extracellular volume and
increases cardiac output, which will increase
BP if there is no compensatory decline in pe-
ripheral resistance (25). Thus, an unchanged
or increased peripheral resistance, coupled
with a sodium-induced increase in cardiac
output, results in an SS BP response, as ob-
served in African Americans (25).
The autonomic nervous system may play
an important role in SS BP. Rodent studiesdemonstrate that modest plasma sodium elevations
from high dietary sodium may signal to the brain,
causing elevated sympathetic outﬂow (26). Other
studies demonstrate a central interaction between
sodium and angiotensin II, which increases sympa-
thetic outﬂow, which targets the splanchnic (27) and
renal (28) circulations and may be an important
mechanism in SS BP. Studies in humans support a link
between plasma sodium and BP (29,30), and osmo-
lality and sympathetic outﬂow (31), but these ﬁndings
are not consistent (32). Extremely low sodium diets
(w230 mg) over a short time period (6 days) are
associated with increased sympathetic outﬂow in
humans (33).
The standard laboratory rat is SR, but SS strains
have been bred (34). For example, Dahl (35) fed
Sprague-Dawley rats high-sodium chow and grouped
them according to BP response, developing the DahlDietary Salt and Health
ally exert its inﬂuence through various mechanisms to cause an inc
hange (D) in BP varies considerably, even within a given populatioSS and SR lineages. Although SS BP is heritable,
outside of monogenic renal tubular disorders causing
sodium retention and HTN, the genetic underpinnings
of “routine” salt sensitivity in humans are unknown
(19). There has been recent progress in understanding
genetic mechanisms, such as the GenSalt studies in
China, which identiﬁed angiotensin II type 1 gene
variants predictive of salt sensitivity (18). Genome-
wide association studies and overall BP studies have
had limited success—genetic loci associated with a
small effect on BP have been identiﬁed (36), which is
likely to be the case with SS BP responses.
PATHOPHYSIOLOGY:
SODIUM AND TARGET ORGAN EFFECTS
There is evidence that in the absence of increased
BP, elevated dietary sodium can adversely affect
multiple target organs and tissues (19), including therease in blood pressure (BP) through alterations in cardiac output and
n (as depicted in the distribution). AT1 ¼ angiotensin II receptor type 1.
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1045vasculature, heart, kidneys, and areas of the brain
that control autonomic outﬂow (Figure 1).
ARTERIES. Rodent studies demonstrated impaired
endothelial function during sodium loading, without
alterations in BP (37–40). Sodium loading in normo-
tensive men reduced endothelial function (41),
and sodium restriction in adults with elevated BP
improved endothelial function (42). Additionally,
high sodium impairs endothelial function in normo-
tensive SR humans, providing support for a BP-
independent effect of sodium on the endothelium
(43,44). Sodium’s deleterious effects on endothelial
function likely result from reactive oxygen species
(38,44), such as superoxide (39,40), resulting in
reduced nitric oxide bioavailability. Cell culture
studies support that high sodium exposure stiffens
endothelial cells and damages the glycocalyx (45).
Animal studies show that elevated dietary sodium
can increase arterial stiffness independent of BP (46).
In human studies, increased arterial stiffness was
observed in groups with higher sodium intake, inde-
pendent of BP (47,48). This increased stiffness is
likely related to the proﬁbrotic effects of transformingFIGURE 1 BP-Independent Effects of High Dietary Sodium
High dietary sodium can cause target organ damage andmay have
direct effects on the brain, heart, kidneys, and vasculature. These
effects can be independent of changes in blood pressure (BP).growth factor–beta (49). Thus, high sodium stiffens
the arteries, and reducing dietary sodium lowers
arterial stiffness in hypertensive patients (50,51).
HEART AND KIDNEYS. Increased BP is a major risk
factor for left ventricular (LV) hypertrophy; high
dietary sodium may increase LV wall thickness
(52) and mass (53), independent of HTN status. For
example, among a cohort of healthy adults with
minimal HTN, those with the highest sodium excre-
tion had greater LV mass (53). High aldosterone levels
may be important in mediating the effect of dietary
salt on LV mass (54). Also, a 12-month sodium re-
striction intervention in hypertensive patients has
been shown to reduce LV hypertrophy (55).
There are a limited number of studies of subjects
without kidney disease, but evidence suggests that
high sodium is associated with reduced renal func-
tion (56). Sodium loading in spontaneously hyper-
tensive rats increased renal vascular resistance,
glomerular pressure, serum creatinine, and protein-
uria; sodium loading also caused a decline in single-
nephron plasma ﬂow. This decline in renal function
was observed with only a minimal additional increase
in BP (57). Sodium restriction has been shown to
reduce protein excretion and BP in black hyperten-
sive patients (58). Similarly, in the LowSalt CKD
study (59), low salt reduced proteinuria, albuminuria,
and BP.
BRAIN. Sodium may affect brainstem nuclei that
control BP (34). Chronically elevated dietary sodium
may “sensitize” sympathetic neurons in the rostral
ventral lateral medulla of rodents (60–62), causing a
greater sympathetic response to a variety of stimuli
(63), including skeletal muscle contraction (64). This
increased responsiveness has been associated with
increased BP variability, even without an elevation in
average BP (65); this is relevant because of the asso-
ciation of BP variability with target organ damage
(66). Even in the absence of increased BP, chronically
increased sympathetic outﬂow may have deleterious
target organ effects.
EPIDEMIOLOGY: DIETARY SODIUM, BP, AND
CARDIOVASCULAR OUTCOMES
Studying the effect of salt restriction on clinical
outcomes raises signiﬁcant challenges, including: 1)
assessment of sodium intake (best evaluated by
multiple measurements of 24-h sodium urine excre-
tion); 2) long-term maintenance on a deﬁned salt
intake regimen; and 3) the necessity for large
numbers of patients and long-term follow-up to
obtain enough outcomes for analysis. Randomized
controlled clinical trials (RCTs) between groups with
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bias but have largely been limited to short-term
evaluation of the effect of salt restriction on BP, as
larger studies with the longer time frames required
to evaluate the effects of sodium on cardiovascular
(CV) events have not been feasible.
SALT INTAKE AND BP. Multiple meta-analyses and
systematic reviews of RCTs have shown a strong
positive association between sodium intake and sys-
tolic BP (67–73) and a signiﬁcant reduction in systolic
BP with sodium restriction (74,75). A recent meta-
analysis of 103 randomized interventions conﬁrmed
these results, showing a linear association between
salt restriction and systolic BP. The reduction was
larger with older age, among blacks, and among hy-
pertensive patients (76,77). The incidence of HTN
also decreased after a sodium intake reduction
intervention in the Trials of Hypertension Prevention
II RCT (78).
SALT INTAKE AND CV OUTCOMES. Few randomized
trials have sufﬁcient power and long enough follow-
up to examine the effects of sodium restriction on
CV outcomes (79). In a meta-analysis of 7 randomized
sodium reduction trials with follow-up periods of
at least 6 months, Taylor et al. (80) did not ﬁnd any
effect of sodium restriction on all-cause mortality, CV
mortality, or CV morbidity. However, He and Mac-
Gregor (81) replicated this analysis after excluding 1
trial with methodological issues related to the patient
population (patients with heart failure) and showed
that a modest reduction in salt intake resulted in
a signiﬁcant 20% decrease in CV and stroke events.
Most of the studies examining the association be-
tween salt intake and CV events are observational
cohort studies and, as described in an American Heart
Association (AHA) report (82), are subject to multipleTABLE 2 Methodological Issues With Cohort Studies That Relate
Sodium Intake to Cardiovascular Disease*
Errors with the greatest potential to alter the direction of association
in either direction
 Systematic error in sodium assessment
 Reverse causality
Errors with some potential to alter the direction of association in
either direction
 Residual confounding
 Inadequate follow-up
Errors with potential to lead to a false null result
 Random error in sodium assessment
 Insufﬁcient power
*Data derived from Cobb et al. (82) (source: American Heart Association, Inc.).methodological issues. As listed in Table 2, errors
with the greatest potential to alter the association
in either direction are: 1) systematic errors in sodium
assessment, most frequently related to measure-
ments of sodium intake through food frequency
questionnaires, 24-h recall, spot or overnight urine
collection, or 24-h urine collection without evidence
of quality control measures; and 2) reverse causality
related to recruiting sick patients who may consume
less sodium as part of a therapeutic strategy or
reduced overall food consumption or to not excluding
sick participants from general population studies.
Cobb et al. (82) found evidence of systematic error
in sodium assessment in 77% of studies that showed
direct associations between salt intake and CV
events, in 75% of those with inverse associations,
in 100% (only 2 studies) of those with J-shaped as-
sociations, and in 100% of those that showed null
associations. Reverse causality was found in 31%
of those that showed direct associations, in 38% of
those with inverse associations, in 50% of those with
J-shaped associations, and in none of those with null
associations. Considering these results, and that 3
to 4 methodological issues were identiﬁed in each
study (82), systematic reviews and meta-analyses of
observational studies should be evaluated with
circumspection. Since the AHA methodology report
was published, O’Donnell et al. (83), in an analysis of
the PURE (Prospective Urban Rural Epidemiology)
data, a prospective observational study of 101,945
adults, described a J-shaped relationship between
sodium excretion and CV events, with increased CV
events at <3 and $7 g/day. This was maintained even
after restricting the population to a low-risk cohort
and excluding events occurring within 2 years to limit
reverse causality. However, each patient’s sodium
excretion was estimated from a single fasting morn-
ing urine specimen, overestimating the 24-h uri-
nary excretion and likely introducing a systematic
error in sodium assessment according to the AHA
Science Advisory’s classiﬁcation (82). There may
also have been reverse causality. A subsequent anal-
ysis of the observational follow-up of the Trials of
Hypertension Prevention, which, according to the
AHA methodology report, has a low potential for
reverse causality and for systematic error in sodium
assessment, showed a 17% increase in CV events for
every 1,000 mg/day increase in sodium (p ¼ 0.054)
and no evidence of a J-shaped relationship (84).
In conclusion, a large body of evidence conﬁrms the
biological plausibility of the association between high
sodium intake and increases in BP and CV events,
whereas the evidence for an association between low
salt intake and adverse events is unclear and largely
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1047conjectural. The association of low sodium intake
with mortality has been speculated to result from
elevated renin-aldosterone activity, sympathetic
activation, and lipid abnormalities (85). However,
meta-analyses suggest no signiﬁcant effect of low
sodium on lipids and no effect on catecholamines (74).
Also, although dramatic short-term reductions in so-
dium may increase renin-angiotensin-aldosterone
activity (86), modest to moderate longer term re-
ductions, as suggested by the AHA or the Institute of
Medicine (87,88), may produce only minimal in-
creases (69). Finally, because of the multiple meth-
odological issues associated with cohort studies and
the difﬁculty of organizing a trial to assess the asso-
ciation between sodium intake and CV events, the
AHA recommends sodium on the basis of the large
body of evidence linking sodium intake to BP (82).
LIMITING SODIUM IN THE DIET
Sodium is ubiquitous in the diets of most developed
countries. Although some sodium intake is necessary,
recommendations vary for adequate intake and
tolerable upper intake levels (79,89,90). Physiological
requirements for sodium are <500 mg/day in most
healthy individuals, but the average consumption in
the United States is more than 3,200 mg/day
(2,88,91,92). NHANES (National Health and Nutrition
Examination Survey) data reveal that sodium con-
sumption increased between the early 1970s and the
early 1990s (2,91). NHANES data from 2003 to 2008,
using 24-h dietary recall, show that 99.4% and 97%
of U.S. adults consumed more sodium than recom-
mended by the AHA and the 2010 U.S. Department
of Health and Human Services dietary guideline
for Americans, respectively (79,90). Although there is
general consensus that current sodium consumption
levels are excessive and contribute to CV risk (79,88),
the U.S. Food and Drug Administration considers
sodium added in food preparation to be “generally
regarded as safe,” and there are no standards for
its safe use in food (88).
Most people like some level of salt in food.
Conceptually, there is a “bliss point” at which the
effect of sodium on ﬂavor is optimal (93). However,
this bliss point is malleable, and most people will
adapt (94) to a reduction in dietary sodium (88).
Sudden sodium changes are harder to accept, but if
the United States gradually moves to a diet with less
sodium, many people will likely make the transition
with little difﬁculty (94–96).
Approximately 70% of sodium in the diet is in
processed foods (97–99) and used to prepare foods
as ubiquitous as bread (100). Sodium added in foodpreparation and at the table contributes less (88,98).
Restaurants are also more likely to have saltier foods,
and more people are eating out in recent decades.
Market forces are a factor in the large amount of
sodium in the diet, so without a societal approach,
pressure on individual stakeholders is likely to be
resisted. Food processors have marketed low-sodium
alternatives without much success (101). A partner-
ship of food processors and restaurant associations
with groups such as the AHA is more likely to suc-
cessfully change diets (79). Efforts in Finland and the
United Kingdom have successfully reduced sodium
intake (102–104).
A number of approaches can decrease dietary
sodium: 1) a decrease in the sodium content of foods;
2) a switch on the part of consumers from high-
sodium to low-sodium foods by avoiding processed
foods and reading labels; 3) a switch to substitute
salts (105–107); 4) a reduction in sodium while
increasing other ﬂavors (96,100); and 5) the use of
engineering approaches to provide salty taste with
less sodium or food processing with less sodium
(88,108). Importantly, ﬂavor must be maintained,
because taste is the driving force behind salty foods
(88,109). A decrease in sodium intake from current
levels will represent a major change in our food
supply and may be most successful as a series of small
steps over several years. Coordination among food
processors, restaurants, and advocacy groups is
crucial and currently lacking (88). Importantly,
increased dietary potassium intake may decrease salt
sensitivity and favorably affect BP (110).
Altered dietary sodium intake targets should be
considered for individuals engaging in high physical
activity or exposed to heat stress (111). Although
there may be some sweat loss accommodation in
response to sodium restriction (112), sodium recom-
mendations should be assessed to ensure that sodium
intake matches sweat loss. Although there is general
consensus that the current sodium intake in the
United States (3,200 mg/day) should be lowered, the
Institute of Medicine cautioned against diets contain-
ing <2,300 mg/day sodium for selected groups (113).
CONCLUSIONS
BP correlates with sodium intake, with multiple
mechanisms underlying this relation. Pre-clinical and
clinical studies demonstrate that sodium adversely
affects multiple target organs independent of BP.
Clinical trials have shown decreased BP with
decreased sodium intake, but the studies relating
sodium consumption to CV events have signiﬁcant
limitations related to difﬁculty in assessment of
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power has been a barrier to demonstrating an effect
of reduced sodium on hard outcomes in normoten-
sive people. The difﬁculties of adhering to a sodium
restriction diet over years may be an insurmountable
hurdle for an RCT with enough power to detect a
difference in CV events that could be generalizable to
the entire population. Because of the weight of evi-
dence in favor of salt reduction and the difﬁculties
in organizing a clinical trial, the AHA recommends
a population-wide reduction in sodium intake (87).Reducing sodium will take a coordinated effort
involving organizations such as the AHA, food pro-
ducers and processors, restaurants, and public policy
aimed at education.
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